JP2015510881A5 - - Google Patents

Download PDF

Info

Publication number
JP2015510881A5
JP2015510881A5 JP2014560950A JP2014560950A JP2015510881A5 JP 2015510881 A5 JP2015510881 A5 JP 2015510881A5 JP 2014560950 A JP2014560950 A JP 2014560950A JP 2014560950 A JP2014560950 A JP 2014560950A JP 2015510881 A5 JP2015510881 A5 JP 2015510881A5
Authority
JP
Japan
Prior art keywords
chromeno
pyridin
amino
alkyl
amine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2014560950A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015510881A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/028230 external-priority patent/WO2013134036A1/en
Publication of JP2015510881A publication Critical patent/JP2015510881A/ja
Publication of JP2015510881A5 publication Critical patent/JP2015510881A5/ja
Withdrawn legal-status Critical Current

Links

JP2014560950A 2012-03-09 2013-02-28 アリールエーテルベースのキナーゼ阻害剤 Withdrawn JP2015510881A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261608737P 2012-03-09 2012-03-09
US61/608,737 2012-03-09
PCT/US2013/028230 WO2013134036A1 (en) 2012-03-09 2013-02-28 Aryl ether-base kinase inhibitors

Publications (2)

Publication Number Publication Date
JP2015510881A JP2015510881A (ja) 2015-04-13
JP2015510881A5 true JP2015510881A5 (https=) 2016-04-07

Family

ID=47892007

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014560950A Withdrawn JP2015510881A (ja) 2012-03-09 2013-02-28 アリールエーテルベースのキナーゼ阻害剤

Country Status (11)

Country Link
US (2) US8703953B2 (https=)
EP (1) EP2822952B1 (https=)
JP (1) JP2015510881A (https=)
CN (1) CN104144932A (https=)
AR (1) AR090293A1 (https=)
CA (1) CA2866671A1 (https=)
EA (1) EA201491647A1 (https=)
MX (1) MX2014010684A (https=)
TW (1) TW201341387A (https=)
UY (1) UY34666A (https=)
WO (1) WO2013134036A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8901305B2 (en) 2012-07-31 2014-12-02 Bristol-Myers Squibb Company Aryl lactam kinase inhibitors
US9708337B2 (en) 2013-02-22 2017-07-18 Bristol-Myers Squibb Company Aryl amide-based kinase inhibitors
US9914740B2 (en) 2013-07-02 2018-03-13 Bristol-Myers Squibb Company Tricyclic pyrido-carboxamide derivatives as rock inhibitors
EP3016950B1 (en) 2013-07-02 2017-06-07 Bristol-Myers Squibb Company Tricyclic pyrido-carboxamide derivatives as rock inhibitors
US10253027B2 (en) 2013-07-08 2019-04-09 Bristol-Myers Squibb Company Aryl lactam kinase inhibitors
EP3044226B1 (en) * 2013-09-11 2017-09-06 Bristol-Myers Squibb Company Aryl ether-base kinase inhibitors
WO2015054358A1 (en) 2013-10-11 2015-04-16 Bristol-Myers Squibb Company Pyrrolotriazine kinase inhibitors
JP6276865B2 (ja) * 2014-01-29 2018-02-07 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company アリールラクタムキナーゼ阻害剤
ES2701903T3 (es) * 2014-01-31 2019-02-26 Bristol Myers Squibb Co Inhibidores de cinasa a base de quinolina
SMT201800665T1 (it) 2014-04-02 2019-01-11 Bristol Myers Squibb Co Inibitori biarilici di chinasi
ES2740224T3 (es) 2015-04-10 2020-02-05 Bristol Myers Squibb Co 6H-isocromeno[3,4-c]piridinas y benzo[c][1,7]naftiridin-6-(5H)-onas como inhibidores de la cinasa asociada a adaptador 1 (AAK1)
BR112017019207A2 (pt) * 2015-05-22 2018-04-24 Dow Agrosciences Llc recuperação e/ou reutilização de catalisador de paládio após acoplamento de suzuki
JP6864674B2 (ja) * 2015-10-01 2021-04-28 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company ビアリールキナーゼ阻害剤
WO2017059085A1 (en) * 2015-10-01 2017-04-06 Bristol-Myers Squibb Company Biaryl kinase inhibitors
SG10202009148XA (en) 2016-12-15 2020-10-29 Hoffmann La Roche Process for preparing btk inhibitors

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU673569B2 (en) 1992-12-02 1996-11-14 Pfizer Inc. Catechol diethers as selective PDE-IV inhibitors
US5709861A (en) 1993-04-22 1998-01-20 Emisphere Technologies, Inc. Compositions for the delivery of antigens
US20070060606A1 (en) * 1999-10-07 2007-03-15 Robertson Harold A Compounds and methods for modulating phosphodiesterase 10A
AU2003230772A1 (en) 2002-04-05 2003-10-27 Boehringer Ingelheim Pharmaceuticals, Inc. Cyanamides useful as reversible inhibitors of cysteine proteases
WO2004056744A1 (en) 2002-12-23 2004-07-08 Janssen Pharmaceutica N.V. Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors
WO2004072018A1 (ja) 2003-02-12 2004-08-26 Takeda Pharmaceutical Company Limited アミン誘導体
WO2005000309A2 (en) 2003-06-27 2005-01-06 Ionix Pharmaceuticals Limited Chemical compounds
US20050288338A1 (en) 2004-06-24 2005-12-29 Wenqing Yao Amido compounds and their use as pharmaceuticals
CN100494167C (zh) 2005-08-02 2009-06-03 天津大学 抗乙肝病毒的叔胺氧化物及制备方法和制备药物的应用
JP2007217408A (ja) 2006-01-19 2007-08-30 Tanabe Seiyaku Co Ltd 医薬組成物
EP2674428B1 (en) 2006-04-07 2016-04-06 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
US20080039535A1 (en) 2006-08-14 2008-02-14 Wyeth Methods of identifying agents for treating neurological disorders
US20100183514A1 (en) * 2007-05-29 2010-07-22 President And Fellows Of Harvard College Molecules involved in regulation of osteoblast activity and osteoclast activity, and methods of use thereof
DE102007025717A1 (de) * 2007-06-01 2008-12-11 Merck Patent Gmbh Arylether-pyridazinonderivate
US8497271B2 (en) 2009-10-07 2013-07-30 Bristol-Myers Squibb Company Modulators of G protein-coupled receptor 88
US8426414B2 (en) 2009-10-09 2013-04-23 Bristol-Myers Squibb Company Modulators of G protein-coupled receptor 88

Similar Documents

Publication Publication Date Title
JP2015510881A5 (https=)
JP2018533611A5 (https=)
ME02635B (me) Novi derivati pirola, postupak njihove priprave i farmaceutski pripravci koji ih sadrže
ME02202B (me) Jedinjenja pirolopirimidina kao inhibitori cdk4/6
RU2015148189A (ru) ПРОИЗВОДНЫЕ 2-АМИДОПИРИДО[4, 3-d]ПИРИМИДИН-5-ОНА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ИНГИБИТОРОВ WEE-1
RU2009123930A (ru) Химические соединения 637: пиридопиримидиндионы в качестве ингибиторов pde4
RU2013143292A (ru) Триазолопиридиновые соединения как ингибиторы киназы pim
JP2018507214A5 (https=)
RU2018103944A (ru) Производные этинила как модуляторы метаботропного рецептора глутамата
RU2019115115A (ru) Производные пиперидина в качестве ингибиторов убиквитин-специфической протеазы 7
FI3768674T3 (fi) Aminopyrimidiinijohdannaisia ctps1:n estäjinä
JP2016518372A5 (https=)
JP2013519707A5 (https=)
JP2010513523A5 (https=)
MX379425B (es) 7-bencil-4-(2-metilbencilo) -2,4,6,7,8,9-hexahidroimidazo [1,2-a] pirido [3,4-e] pirimidin-5 (1h) -ona, análogos y sales del mismo y su uso en terapia.
RU2011108281A (ru) Трипиридилкарбоксамидные антагонисты орексиновых рецепторов
JP2013510124A5 (https=)
RU2016130932A (ru) Производные хинолона как ингибиторы рецептора фактора роста фибробластов
JP2015528018A5 (https=)
RU2016141569A (ru) Комбинации
JP2013529196A5 (https=)
RU2014109748A (ru) Морфолино-замещенные производные бициклических пиримидинмочевины или карбамата в качестве ингибиторов mtor
JP2019503337A5 (https=)
JP2016537384A5 (https=)
JP2016520118A5 (https=)